Francis Chris bought WVE
January 2, 2026 · Form 4 insider transaction
Francis Chris bought 9,375 shares of Wave Life Sciences, Inc. at $3.14 per share, a transaction worth $29.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,375
Price
$3.14
Total value
$29.4K
InsiderFrancis Chris
RoleOfficer
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after34,375
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.